These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29704547)

  • 1. Predictive performance of a gentamicin population pharmacokinetic model in two western populations of critically ill patients.
    Bukkems LH; Roger C; Hodiamont CJ; Lefrant JY; Juffermans NP; Roberts JA; van Hest RM
    Int J Antimicrob Agents; 2018 Aug; 52(2):218-225. PubMed ID: 29704547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of daptomycin in critically ill patients.
    Soraluce A; Asín-Prieto E; Rodríguez-Gascón A; Barrasa H; Maynar J; Carcelero E; Soy D; Isla A
    Int J Antimicrob Agents; 2018 Aug; 52(2):158-165. PubMed ID: 29572042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered.
    Veinstein A; Venisse N; Badin J; Pinsard M; Robert R; Dupuis A
    Antimicrob Agents Chemother; 2013 Feb; 57(2):977-82. PubMed ID: 23229487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.
    Yagasaki K; Gando S; Matsuda N; Kameue T; Ishitani T; Hirano T; Iseki K
    Intensive Care Med; 2003 Nov; 29(11):2094-5. PubMed ID: 14504724
    [No Abstract]   [Full Text] [Related]  

  • 7. Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF).
    D'Arcy DM; Corrigan OI; Deasy E; Gowing CM; Donnelly MB
    Eur J Clin Pharmacol; 2015 Mar; 71(3):377-8. PubMed ID: 25567215
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
    Sridharan K; Al Daylami A
    J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
    Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
    Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics with Monte Carlo Simulations of Gentamicin in a Population of Severely Ill Adult Patients from Sub-Saharan Africa.
    Bos JC; Prins JM; Mistício MC; Nunguiane G; Lang CN; Beirão JC; Mathôt RAA; van Hest RM
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients.
    Hodiamont CJ; Janssen JM; de Jong MD; Mathôt RA; Juffermans NP; van Hest RM
    Ther Drug Monit; 2017 Oct; 39(5):522-530. PubMed ID: 28682925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia.
    Sampson MR; Frymoyer A; Rattray B; Cotten CM; Smith PB; Capparelli E; Bonifacio SL; Cohen-Wolkowiez M
    Ther Drug Monit; 2014 Oct; 36(5):584-9. PubMed ID: 25225917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic Models.
    Duong A; Marsot A
    Clin Pharmacol Drug Dev; 2024 Jul; 13(7):739-747. PubMed ID: 38465725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
    Roberts JA; Field J; Visser A; Whitbread R; Tallot M; Lipman J; Kirkpatrick CM
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3635-40. PubMed ID: 20547809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
    Staatz CE; Byrne C; Thomson AH
    Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationality of administered gentamicin dose in cerebral coma patients treated in an intensive care unit.
    Janušonis T; Mačiulaitis R; Sveikata A; Milašius A; Kregždytė R
    Medicina (Kaunas); 2011; 47(2):79-84. PubMed ID: 21734439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.